Roy Gerona, PhD
Associate Professor
Ob/Gyn, Reproductive Sciences
School of Medicine

415-502-1446

My research focus is on the development of mass spectrometric techniques and their application to environmental biomonitoring, clinical toxicology, and therapeutic drug monitoring in MDR-TB patients.

Show full bio (290 words) Hide full bio

In biomonitoring, my laboratory is pioneering the application of high resolution mass spectrometry to the suspect screening of environmental chemicals in biological samples. We have have also continuously developed innovative and sensitive liquid chromatography- mass spectrometry (LC-MS) methods for measuring environmental chemicals (e.g. environmental phenols such as BPA, BPS and triclosan; phthalate metabolites; perfluorinated compounds; pesticides; and, flame retardants) in a variety of biological matrices including serum, urine, amniotic fluid, placenta, hair, and other human and animal tissues.

My laboratory also specializes in the analysis of new psychoactive substances (NPS) using high resolution and tandem mass spectrometry to aid Poison Centers, Medical Examiner’s Offices, and various government agencies including the Drug Enforcement Administration, the Centers for Disease Control and Prevention, and the National Institute of Occupational Safety and Health, in tracking down synthetic drug intoxications and epidemics. In 2016 I established the Pshychoactive Substances Consortium and Analysis Network (PSCAN), a consortium of ten medical centers prospectively collecting cases that may have NPS etiology to pair comprehensive clinical data with NPS analysis data in their corresponding biological samples with the aim of potentially defining toxidromes specific to various NPS classes. This year my laboratory has been awarded by a Department of Justice (DOJ)- DEA research contract to conduct the national surveillance on NPS intoxications and mass outbreak.

More recently, I have also started working with the Positive Health Program at San Francisco General Hospital to develop LC-MS methods for hair TB drug monitoring in HIV/AIDS patients and related studies. We have successfully developed an LC-MS/MS panel to simultaneously measure 11 TB drugs in hair including new drug-resistant TB medications. The panel is currently being used for drug adherence monitoring among multi-drug resistant TB patients.

Education & Training

Show all (4) Hide

  • Post-Doctoral Fellowship- Clinical Chemistry Department of Laboratory Medicine University of California San Francisco 2011
  • PhD Biochemistry Department of Biochemistry University of Wisconsin, Madison 2008
  • MS Biochemistry Institute of Chemistry University of the Philippines 1998
  • BS Chemistry Institute of Chemistry University of the Philippines 1990

Interests

Show all (14) Hide

  • Synthetic cannabinoids
  • Mass spectrometry
  • Opioid Analogs
  • Biomonitoring of environmental chemicals
  • Hair antiretroviral analysis
  • High Resolution Mass Spectrometry
  • Clinical Toxicology
  • HIV/AIDS Therapeutic drug monitoring
  • Environmental health
  • Designer drugs (New Psychoactive Substances)
  • Analytical Toxicology
  • Hair TB drug analysis
  • Endocrine disruptors
  • Suspect screening

Websites

Show all (1) Hide

Grants and Projects

Show all (4) Hide

  • Toxicology Testing of Biological Samples of Overdose Patients Resulting from the Ingestion of Novel Psychoactive Substances, DOJ/DEA, 2019-2024
  • Establishment of the University of the Philippines Drugs of Abuse Research laboratory, Philippine-CA Advanced Research Institutes, 2018-2020
  • Establishment of a Philippine Cancer Phenome Biobanking System and Biomonitoring Program, Philippine-CA Advanced Research Institutes, 2017-2019
  • Meiotic Studies of Chemicals with Estrogenic Activity, NIH, 2005-2018

Publications (164)

Top publication keywords:
CannabinoidsDrug StabilityEndocrine DisruptorsHairIndazolesPsychotropic DrugsBenzhydryl CompoundsSubstance Abuse DetectionTandem Mass SpectrometryCannabinoid Receptor AgonistsPhenolsDesigner DrugsChromatography, LiquidTuberculosis, Multidrug-ResistantAntitubercular Agents

Show all (159 more) Hide